Literature DB >> 17638062

Acute onset paraneoplastic cerebellar degeneration.

Anastasios Bonakis, Sokratis G Papageorgiou, Dimitrios Mandellos, Eleni Galani, Nikolaos Kalfakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17638062     DOI： 10.1007/s11060-007-9368-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.506


× No keyword cloud information.
  10 in total

1.  Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies.

Authors:  J E Hammack; D W Kimmel; B P O'Neill; V A Lennon
Journal:  Mayo Clin Proc       Date:  1990-11       Impact factor: 7.616

2.  Acute onset paraneoplastic cerebellar degeneration in a patient with small cell lung cancer.

Authors:  R Bhatia; S Prabhakar; V Lal; D Khurana; C P Das
Journal:  Neurol India       Date:  2003-06       Impact factor: 2.117

3.  Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage.

Authors:  J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

4.  Paraneoplastic cerebellar degeneration: new insights into imaging and immunology.

Authors:  J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 5.  Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.

Authors:  Y Cao; J Abbas; X Wu; J Dooley; A L van Amburg
Journal:  Gynecol Oncol       Date:  1999-10       Impact factor: 5.482

6.  Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Authors:  I Rojas; F Graus; F Keime-Guibert; R Reñé; J Y Delattre; J M Ramón; J Dalmau; J B Posner
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

7.  Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.

Authors:  P F Ypma; P W Wijermans; H Koppen; P A E Sillevis Smitt
Journal:  Neth J Med       Date:  2006 Jul-Aug       Impact factor: 1.422

8.  Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

Authors:  F Keime-Guibert; F Graus; A Fleury; R René; J Honnorat; P Broet; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

9.  Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients.

Authors:  M Drlicek; G Bianchi; G Bogliun; B Casati; W Grisold; C Kolig; U Liszka-Setinek; L Marzorati; E Wondrusch; G Cavaletti
Journal:  J Neurol       Date:  1997-02       Impact factor: 4.849

10.  Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.

Authors:  Anette Storstein; Sissel E Monstad; Jerome Honnorat; Christian A Vedeler
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478
  10 in total
  2 in total

Review 1.  Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature.

Authors:  Alberto Vogrig; Andrea Bernardini; Gian Luigi Gigli; Elisa Corazza; Alessandro Marini; Samantha Segatti; Martina Fabris; Jérôme Honnorat; Mariarosaria Valente
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

2.  Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma.

Authors:  Emmanouel Saloustros; Ioannis Zaganas; Michail Mavridis; Lambros Vamvakas; Andreas Plaitakis; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  J Neurooncol       Date:  2009-10-02       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.